← back to search

Niki Stavroyianni

G. Papanikolaou General Hospital ·
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, and Monoclonal and Polyclonal Antibodies Research.
h-index
29
citations
3,254
works
172
NIH funding
primary concept
Medicine
email

Recent publications

<i>BTK</i> and <i>PLCG2</i> remain unmutated in one-third of patients with CLL relapsing on ibrutinib
Blood Advances 2023cited by 65position: middledoi
Clonal haematopoiesis as a risk factor for therapy‐related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo‐(immuno)therapy
British Journal of Haematology 2022cited by 21position: middledoi
Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study
Blood 2022cited by 0position: middledoi
Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL
Blood 2022cited by 0position: middledoi
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
Leukemia 2021cited by 94position: middledoi
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Leukemia 2020cited by 275position: middledoi
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Blood 2020cited by 129position: middledoi
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Blood 2019cited by 234position: middledoi
DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
Clinical Epigenetics 2019cited by 22position: middledoi
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Clinical Cancer Research 2017cited by 35position: middledoi
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
Blood 2016cited by 99position: middledoi
ΝFΚΒΙΕ Deletions: A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma
Blood 2016cited by 0position: middledoi
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
Blood 2015cited by 153position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Karla Plevová · Central European Institute of Technology2 papers (2019–2022)Paolo Ghia · Vita-Salute San Raffaele University2 papers (2019–2022)Κώστας Σταματόπουλος · Karolinska Institutet2 papers (2019–2022)Viktor Ljungström · Uppsala University2 papers (2019–2022)Šárka Pospı́šilová · Central European Institute of Technology1 papers (2019–2019)Matthias Ritgen · University Hospital Schleswig-Holstein1 papers (2019–2019)Emiliano Fabiani · Harvard Stem Cell Institute1 papers (2022–2022)Chiara Salvetti · Sunnybrook Health Science Centre1 papers (2022–2022)Nikos Papakonstantinou · Science for Life Laboratory1 papers (2019–2019) · 1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2019–2019)David Oscier · Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust1 papers (2019–2019)Christiane Pott · University of Tübingen1 papers (2019–2019) · 1 papers (2022–2022)Theodoros Moysiadis · University Hospital of Alexandroupolis1 papers (2019–2019) · 1 papers (2022–2022)Livio Trentin · Veneto Institute of Molecular Medicine1 papers (2019–2019)Martí Duran‐Ferrer · Consorci Institut D'Investigacions Biomediques August Pi I Sunyer1 papers (2019–2019) · 1 papers (2022–2022)